Evidence map›Paper›PMID 29789480›Full record

ReviewInternational journal of molecular sciences2018

Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.

Liangfu Zhou, Bin Zhao, Lixiu Zhang, Shenghang Wang, Dandan Dong, Huanhuan Lv, Peng Shang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Transmetalation in Cancer Pharmacology.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. FeCurrent microbiology · 2025
    Article
  10. Frontiers in oncology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liangfu ZhouSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. zlf19900919@mail.nwpu.edu.cn.
Bin ZhaoSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. zhao000bin@mail.nwpu.edu.cn.
Lixiu ZhangSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. zlx1992@mail.nwpu.edu.cn.
Shenghang WangSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. wangshenghang@mail.nwpu.edu.cn.
Dandan DongSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. ddd2013@mail.nwpu.edu.cn.
Huanhuan LvSchool of Life Science, Northwestern Polytechnical University, Xi'an 710072, China. lvhh2017@nwpu.edu.cn.
Peng ShangResearch & Development Institute in Shenzhen, Northwestern Polytechnical University, Shenzhen 518057, China. shangpeng@nwpu.edu.cn.
Northwestern Polytechnical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron is an essential element for the growth and proliferation of cells. Cellular iron uptake, storage, utilization and export are tightly regulated to maintain iron homeostasis. However, cellular iron metabolism pathways are disturbed in most cancer cells. To maintain rapid growth and proliferation, cancer cells acquire large amounts of iron by altering expression of iron metabolism- related proteins. In this paper, normal cellular iron metabolism and the alterations of iron metabolic pathways in cancer cells were summarized. Therapeutic strategies based on targeting the altered iron metabolism were also discussed and disrupting redox homeostasis by intracellular high levels of iron provides new insight for cancer therapy. Altered iron metabolism constitutes a promising therapeutic target for cancer therapy.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsHomeostasisHumansIronNeoplasmsOxidation-ReductionAntineoplastic AgentsAntioxidantsIroncanceriron chelatorsiron metabolismredox homeostasistargeted therapy

Identifiers

PMID29789480
PMCPMC5983609
OpenAlexW2803768106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.